D-0072-2024 Class III Terminated

Recalled by Denver Solutions, LLC DBA Leiters Health — Englewood, CO

FDA drug recall D-0072-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Oct 4, 2023 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 25,908 IV bags.

Recall details

Product Type
Drugs
Report Date
Nov 1, 2023
Initiation Date
Oct 4, 2023
Termination Date
Aug 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
25,908 IV bags

Product description

VANCOmycin HCI PF, 1.5 g added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-029-68.

Reason for recall

Labeling: Not Elsewhere Classified

Distribution pattern

USA Nationwide

Code information

Lot#: 2330792, Exp. 12/17/23; 2330801, Exp. 12/26/23; 2330821, 10/15/23; 2330823, Exp. 10/21/23; 2330825, Exp. 10/27/23; 2330846, Exp. 10/28/23; 2330847, Exp. 11/03/23; 2330856, 11/17/23; 2330858, Exp. 12/03/23; 2330860, 12/15/23; 2330866, Exp. 12/29/23; 2331053, Exp. 01/13/24.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0072-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0072-2024. Report a data issue: hello@regdatalab.com.